Home › NDC Lookup › Ingredients › Benzocaine, Lidocaine, Tetracaine › 73341-0001-30
BLT Skin Cream Benzocaine, Lidocaine, Tetracaine .2 g/g; .01 g/g; .04 g/g Cream, 30 g — NDC 73341-0001-30 package photo

BLT Skin Cream Benzocaine, Lidocaine, Tetracaine .2 g/g; .01 g/g; .04 g/g Cream, 30 g

by M2B Pharma LLC · 30 g in 1 JAR (73341-001-30)
NDC 73341-0001-30
🏷️ FDA NDC (as labeled) 73341-001-30 billing pads the product segment with a zero
This package
Contains30 g Pack sizes2 compare ↓
Also comes in: 454 g 73341-0001-01
OTC On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 73341-001-30
Product NDC 73341-001
11-digit billing NDC 73341000130
NCPDP billing unit GM — per gram (weight)
RxCUI 2275621
UNII U3RSY48JW5, 0619F35CGV, 98PI200987
UPC 0373341001303
Application # M017
SPL Set ID 9dc5db9d-9e0a-cd28-e053-2995a90a6bf7
Established class (EPC) Standardized Chemical Allergen; Ester Local Anesthetic; Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Local Anesthesia
Chemical class Allergens; Esters; Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-02-04
Route TOPICAL
Dosage form CREAM
Substance BENZOCAINE; TETRACAINE; LIDOCAINE
Why two NDCs? The FDA registers this code as 73341-001-30 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 73341-0001-30. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Ester Local Anesthetic class.

Pharmacologic class Ester Local Anesthetic
Drug family (ATC) Local anesthetics, Anesthetics for topical use, Esters of aminobenzoic acid
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerM2B Pharma LLC
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code73341
First marketedFeb 2020
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

BLT Skin Cream is a topical cream containing three local anesthetic ingredients: benzocaine, lidocaine, and tetracaine. These anesthetic agents are commonly used to numb the skin and reduce discomfort from minor pain, itching, or irritation. This product is an over-the-counter monograph drug, meaning it is manufactured under FDA's established guidelines for its category rather than through individual product approval.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII X7GNG3S47T
    A quaternary ammonium compound used as an antistatic agent and emulsifier in pharmaceutical formulations. It helps reduce static electricity during manufacturing and improves texture or consistency in creams and lotions.
  • UNII 2DMT128M1S
    A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
  • UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • UNII SA6A6V432S
    Dimethyl isosorbide is a clear liquid solvent derived from natural sugar sources. It helps dissolve active ingredients and improve their absorption in liquid medicines and topical products.
  • UNII 147D247K3P
    Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
  • UNII C9H2L21V7U
    A fat derived from coconut or palm oil containing shorter fatty acid chains. It serves as a solvent and carrier to help dissolve or suspend active ingredients, improving absorption and stability in liquid formulations.
  • UNII 6F36Q0I0AC
    PEG-150 distearate is a waxy substance made by combining polyethylene glycol with stearic acid. It acts as an emulsifier and surfactant to help blend water and oil-based ingredients, and may also function as a thickener or lubricant in the formulation.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII 67C1D6YV24
    Polyquaternium 37 is a synthetic polymer used as a thickening agent and viscosity enhancer in liquid medications and topical products. It increases the consistency of formulations to improve texture and help active ingredients spread evenly.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbehentrimonium chloride, caprylic/capric triglyceride, cetearyl alcohol, citric acid, dimethyl isosorbide, ethylhexylglycerin, PEG-150 distearate, phenoxyethanol, polyquaternium-37, water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 454 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
BLT Skin Cream .2 g/g; .01 g/g; .04 g/gthis 73341-0001-30 M2B 30 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2020
On the market since
Feb 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for BLT Skin Cream (this brand).

Top reported reactions

Cardiac Disorder1
Injection Site Discomfort1
Injection Site Pain1
Muscle Spasms1
Shock1
Tachycardia1

Reporter sex

2 reports
Male · 50%
Female · 50%

Serious outcomes

Hospitalization1
Reports over time (by year) — tap or hover for the count & year
2024 2025 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
73341-0001-01 454 g in 1 JAR (73341-001-01) 2020-12-23 Active
73341-0001-30 You're viewing this 30 g in 1 JAR (73341-001-30) 2020-02-04 Active

You're viewing the smallest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in NDC 73341-0001-30?
NDC 73341-0001-30 contains 30 g — 30 g in 1 jar.
What is the difference between NDC 73341-0001-30 and NDC 73341-0001-01?
Both are BLT Skin Cream Benzocaine, Lidocaine, Tetracaine .2 g/g; .01 g/g; .04 g/g Cream — the drug itself is identical. NDC 73341-0001-30 is the 30 g package, while NDC 73341-0001-01 is the 454 g package.
What NDC number is used to bill for this package of BLT Skin Cream Benzocaine, Lidocaine, Tetracaine .2 g/g; .01 g/g; .04 g/g Cream?
Bill NDC 73341-0001-30 — the 11-digit billing format is 73341000130. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 73341-001-30, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 73341-0001-30, written without dashes as 73341000130. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 73341-0001-30, the first segment (73341) is the labeler code FDA assigned to M2B Pharma LLC; the middle segment (0001) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (30) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by M2B Pharma LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 454 g (73341-0001-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
M2B Pharma LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 6 words ▾

Uses For temporary relief of pain

⏱️ Dosage and Administration 42 words ▾

Directions Adults and children over 17 years of age: Apply to affected area of pain no more than 3-4 times per day. Do not cover with any occlusive dressing Do not use on children 17 years and younger without consulting a doctor.

⚠️ Warnings 194 words ▾

Warnings For external use only Do not use On wounds or damaged, broken or irritated skin In large quantities At the same time as other topical analgesics or anesthetics If you are currently taking medication to control heart rate or rhythm or if you have any type of heart disease If you are allergic to PABA, benzocaine, lidocaine, tetracaine or other sulfonamides (sulfa) type drugs If you are under the age of 17 When using this product Use only as directed. Read and follow all directions and warnings on this label. Avoid contact with eyes or mucous membrane Do not bandage or cover with any type of clear occlusive dressing Do not apply local heat (such as heating pad) to area of use Stop use and ask a doctor if If redness or skin irritation is present at application site Condition worsens Symptoms persist for more than 7 days or clear up and occur again within a few days You have any heart conditions If pregnant or b reast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 12 words ▾

Active ingredient Benzocaine 20%

Active ingredient Lidocaine 4%

Active ingredient Tetracaine 1%

🧪 Inactive Ingredients 19 words ▾

Inactive I ngredients behentrimonium chloride, caprylic/capric triglyceride, cetearyl alcohol, citric acid, dimethyl isosorbide, ethylhexylglycerin, PEG-150 distearate, phenoxyethanol, polyquaternium-37, water

🎯 Purpose 9 words ▾

Purpose Topical anesthetic

Purpose Topical analgesic

Purpose Topical analgesic

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 73336-0075-07 · Sumitomo 73350-0105-08 · TNT →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.